Literature DB >> 15959656

Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.

Alan Apter, Sefi Kronenberg, David Brent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15959656     DOI： 10.1007/s00787-005-0474-7

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  7 in total

Review 1.  Clinical practice. Adolescent depression.

Authors:  David A Brent; Boris Birmaher
Journal:  N Engl J Med       Date:  2002-08-29       Impact factor: 91.245

2.  Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression.

Authors:  P Rohde; G N Clarke; P M Lewinsohn; J R Seeley; N K Kaufman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-07       Impact factor: 8.829

3.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

4.  Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders.

Authors:  A Wood; R Harrington; A Moore
Journal:  J Child Psychol Psychiatry       Date:  1996-09       Impact factor: 8.982

5.  Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression.

Authors:  D A Brent; D J Kolko; B Birmaher; M Baugher; J Bridge; C Roth; D Holder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-09       Impact factor: 8.829

6.  Which depressed patients respond to cognitive-behavioral treatment?

Authors:  D Jayson; A Wood; L Kroll; J Fraser; R Harrington
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-01       Impact factor: 8.829

7.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272
  7 in total
  1 in total

1.  Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study.

Authors:  Shella Schirman; Sefi Kronenberg; Alan Apter; David Brent; Nadine Melhem; Nimrod Pick; Miri Carmel; Amos Frisch; Abraham Weizman; Doron Gothelf
Journal:  J Neural Transm (Vienna)       Date:  2009-10-23       Impact factor: 3.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.